1-2 of 2
Arpamas Seetasith, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health Resource Utilization and Costs Associated with the Use of Obinutuzumab-Based Regimens Are Similar to Rituximab-Based Regimens for the First-Line Treatment of Follicular Lymphoma

Tu My To, PhD, Keith L. Dawson, DNP, MS, Anthony S Masaquel, PhD MPH, Arpamas Seetasith, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4721.
https://doi.org/10.1182/blood-2019-123408
Published: 2019
Journal Articles

Cause of Death in Resistant and Advanced Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs).

Lisa J McGarry, MPH, Chakkarin Burudpakdee, PharmD, Smeet Gala, MS, Arpamas Seetasith, PhD, Merena Nanavaty, MS, Hui Huang, PhD MBA
Journal: Blood
Blood (2014) 124 (21): 5524.
https://doi.org/10.1182/blood.V124.21.5524.5524
Published: 2014